The hypothalamic pituitary adrenal axis in sepsis

Novartis Foundation Symposium

Volumn 280, Issue , 2007, Pages 182-199

  Polito, Andrea ^a   Aboab, Jérôme ^a   Annane, Djillali ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PHYSIOLOGY; REVIEW; SEPSIS;

ANIMALS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; SEPSIS;

EID: 34247170365     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (65)

1. Abel SM, Back DJ 1993 Cortisol metabolism in vitro - III. Inhibition of microsomal 6 betahydroxylase and cytosolic 4-ene-reductase. J Steroid Biochem Mol Biol 46:827-832
2. Absalomon A, Pledger D, Kong A 1999 Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia 54:861-867
3. Almawi WY 2001 Molecular mechanisms of glucocorticoids effects. Mod Asp Immunobiol 2:78-82
4. Annane D 2005 ICU physicians should abandon the use of etomidate! Intensive Care Med 31:325-326
5. Annane D, Bellissant E, Sebille V et al 1998 Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 46:589-597
6. Annane D, Sebille V, Troche G, Raphael JC, Gajdois P, Bellisant E 2000 A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 283:1038-1045
7. Annane D, Sebille V, Carpentier C et al 2002 Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871
8. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y 2004 Corticosteroids for treating severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329:480
9. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP 1995 Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95: 2435-2441
10. Beishuizen A, Vermes I, Hylkema BS, Haanen C 1999 Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 353:1675-1676
11. Beishuizen A, Thijs LG, Vermes I 2001a Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Intensive Care Med 27:1584-1591
12. Beishuizen A, Thijs LG, Haanen C, Vermes I 2001b Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 86:2811-2816
13. Bellisant E, Annane D 2000 Effect of hydrocortisone on phenylephrine: mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther 68:293-303
14. Bernard GR, Luce JM, Sprung CL et al 1987 High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317:1565-1570
15. Berneis K, Staub JJ, Gessler A, Meier C, Girard J, Muller B 2002 Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab 87: 5470-5474
16. Bernier J, Jobin N, Emptoz-Bonneton A et al 1998 Decreased corticosteroid-binding globulin in burn patients: Relationship with interleukin-6 and fat in nutritional support. Crit Care Med 26:452-460
17. Bollaert PE, Charpentier C, Levy B et al 1998 Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26:645-650
18. Briegel J, Kellermann W, Forst H et al 1994 Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome. The phospholipase A2 study group. Clin Investig 72:782-787
19. Briegel J, Forst H, Haller M et al 1999 Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 27:723-732
20. Cavaillon J 2000 Action of glucocorticoids in the inflammatory cascade. Réanim Urgences 9:605-612
21. Charmandari E, Chrousos GP, Ichijo T et al 2005 The human glucocorticoid receptor (hGR) beta-isoform suppresses the transcriptional activity of hGR-alpha by interfering with formation of active coactivator complexes. Mol Endocrinol 19:52-64
22. Chawla K, Kupfer Y, Tessler S 1999 Hydrocortisone reverses refractory septic shock. Crit Care Med 27:A33
23. Chrousos G 1995 The hypothalamic-pituitary-adrenal axis and immunomediated inflammation. N Engl J Med 332:1351-1362
24. Chrousos G 2000 The stress response and immune function: clinical implications. The 1999 Novera H. Spector lecture. In: Neuroimmunomodulation: perspectives at the new millennium p 38-67
25. Chrousos GP, Charmandari E, Kino T 2004 Glucocorticoid action networks-an introduction to systems biology. J Clin Endocrinol Metab 89:563-564
26. Confalonieri M, Urbino R, Potena A et al 2005 Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 171: 242-248
27. Cooper MS, Stewart P 2003 Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348:727-734
28. Cordido F, Alvarez-Castro P, Isidro ML, Casanueva FF, Dieguez C 2003 Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Eur J Endocrinol 149: 117-122
29. Dickstein G, Shechner C, Nicholson WE et al 1991 Adrenocorticotropin stimulation test: effect of basal cortisol level, time of day and suggested new sensitive low dose test. J Clin Endocrinol Metab 72:773-778
30. Doe RP, Fernandez R, Seal US 1964 Measurement of corticosteroid-binding globulin in man. J Clin Endocrinol 24:1029-1039
31. Edwardson JA, Bennett GW 1974 Modulation of corticotropin-releasing factor release from hypothalamic synaptosome. Nature 251:425-427
32. Franchimont D, Martens H, Hagelstein MT et al 1999 Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 84:2834-2839
33. Galon J, Franchimont D, Hiroi N et al 2002 Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61-71
34. Graybeal ML, Fang V 1985 Physiological doses of exogenous ACTH. Acta Endocrinol 108: 401-406
35. Hall GM, Lacoumenta S, Hart GR, Burrin JM 1990 Site of action of fentanyl in inhibiting the pituitary-adrenal response to surgery in man. Br J Anaesth 65:251-253
36. Hefezi-Moghadam A, Simoncini T, Yang E et al 2002 Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8:473-479
37. Keh D, BoehnkeT, Weber-Cartens S et al 2003 Immunologic and hemodynamic effects of 'low-dose' hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167:512-520
38. Kino T, Chrousos GP 2004 Glucocorticoid and mineralocorticoid receptors and associated diseases. Essays Biochem 40:137-155
39. Kino T, Gragerov A, Slobodskaya O, Tsopanomichalou M, Chrousos GP, Pavlakis GN 2002 Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. J Virol 76:9724-9734
40. Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP 2003a Tissue glucocorticoid resistance/hypersensitivity syndromes. J Steroid Biochem Mol Biol 85:457-467
41. Kino T, Mirani M, Alesci S, Chrousos GP 2003b AIDS-related lipodystrophy/insulin resistance syndrome. Horm Metab Res 35:129-136
42. Lambers SW, Bruining HA, de Jong FH 1997 Corticosteroid therapy in severe illness. N Engl J Med 337:1285-1292
43. Limbourg FP, Huang Z, Plumier JC et al 2002 Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 110:1729-1738
44. Lu NZ, Cidlowski JA 2005 Translational regulatory receptor gene, longevity, and the complex disorders of Western societies. Mol Cell 18:331-342
45. Marik PE, Zaloga GP 2002 Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 122:1784-1796
46. McKee JI, Finlay WE 1983 Cortisol replacement in severely stressed patients [letter]. Lancet 1:484
47. Melby J 1974 Drug spotlight program: systemic corticosteroid therapy: pharmacology and endocrinologic considerations. Ann Int Med 81:505-512
48. Nye EJ, Grice J, Hokgings GI et al 2001 The insulin hypoglycemia test: hypoglycemic criteria and reproducibility. J Neuroendocrinol 13:524-530
49. Oelkers W 1996 Adrenal insufficiency. N Engl J Med 335:1206-1212
50. Oppert M, Schindler R, Husung C et al 2005 Low-dose hydrocortisone improves shock reversal and reduces cytokine on early hyperdynamic septic shock. Crit Care Med 33:2457-2464
51. Orlikowsky DST, Castel M, Annane D 2003 Acute effect of a single intravenous bolus of 50 mg hydrocortisone on cardiovascular autonomic modulation in septic shock. Crit Care Med 31(suppl):A124
52. Orth DN, Kovacs WJ, DeBold CR 1992 In: Williams textbook of endocrinology. Wilson JD, Foster DW (eds) W.B. Saunders Company, Philadelphia p 489-531
53. Perez SA, Mahaira LG, Demirtzoglou FJ et al 2005 A potential role for hydrocortisone in the positive regulation of IL-15-activated NK cell proliferation and survival. Blood 106: 158-166
54. Pfeifer M, Kanc K, Verhovec R, Koijianic A 2001 Reproducibility of the ITT for assessment of GH and cortisol secretion in normal and hypopituitary adult man. Clin Endocrinol (Oxf )54:17-22
55. Pikis SJ, Granner D 1992 Molecular physiology of the regulation of the hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 54:885-909
56. Rothwell PM, Lawler PG 1995 Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 23:78-83
57. Rothwell PM, Udwadia ZF, Lawler PG 1991 Cortisol response to corticotropin and survival in septic shock. Lancet 337:582-583
58. Schmidt IL, Lahner H, Mann K, Petersenn S 2003 Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. J Clin Endocrinol Metab 88:4193-4198
59. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Francoise G 2004 The neuropathology of septic shock: a prospective case-control study. Brain Pathol 14:21-33
60. Soni A, Pepper GM, Wyrwinski PM et al 1995 Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 98:266-271
61. Tandan SM, Gupta N 2005 Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised trial from India. Am J Respir Crit Care Med [A24] [Poster:326]
62. Tsigos C, Chrousos GP 2002 Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53:865-871
63. Ushiama H, Echizen H, Nachi S, Ohnishi A 2002 Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6 beta-hydroxycortisol. Clin Pharmacol Ther 72:33-43
64. Yildiz O, Doganay M, Aygen B, Guven M, Keleutimur F, Tutuu A 2002 Physiological-dose steroid therapy in sepsis. Crit Care 6:251-259
65. Yudt MR, Jewell CM, Bienstock RJ, Cidlowski JA 2003 Molecular origins for the dominant negative function of human glucocorticoid receptor-beta. Mol Cell Biol 23:4319-4330